Birdwatch Note
2022-10-08 17:39:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
No major peer-reviewed study supports this. The study cited by FLDOH also states: “These data are preliminary, based on surveillance data, and should be interpreted with caution. The results have several limitations…” https://www.factcheck.org/2021/12/no-credible-evidence-covid-19-mrna-vaccines-dramatically-increase-heart-attack-risk-contrary-to-flawed-abstract/ https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html
Written by 4F9E13BBF861C14D34BD7CABE9D712A2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1578539632484311041
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1578802158354448384
- noteId - 1578802158354448384
- participantId - 4F9E13BBF861C14D34BD7CABE9D712A2
- noteAuthorParticipantId -
- createdAtMillis - 1665250741937
- tweetId - 1578539632484311041
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- No major peer-reviewed study supports this. The study cited by FLDOH also states: “These data are preliminary, based on surveillance data, and should be interpreted with caution. The results have several limitations…” https://www.factcheck.org/2021/12/no-credible-evidence-covid-19-mrna-vaccines-dramatically-increase-heart-attack-risk-contrary-to-flawed-abstract/ https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-10-08 17:39:01 UTC (1665250741937) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
752BE5AE7222B47517A7BE6833A2BB396A821B47F2C48C4D6DACB64A56646F1A | ||
2022-10-08 17:39:01 UTC (1665250741937) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
4F9E13BBF861C14D34BD7CABE9D712A2 |
Note Ratings
rated at | rated by | |
2022-10-10 12:41:27 -0500 | 0A7D71553AC1F997D8293C2D98EA7805 | Rating Details |
2022-10-08 19:35:07 -0500 | 0BCC8F4EE9F96B62C8CE9F9E71A8A3F6A09BED06241E7971BB08EAC4E35C379E | Rating Details |
2022-10-08 16:01:40 -0500 | 0E08D6125A127344D4630BAF6191F5D8 | Rating Details |
2022-10-10 05:07:15 -0500 | 152C664EC474246EB3D5BD53CBEFF1A9 | Rating Details |
2022-10-11 11:53:15 -0500 | 18F650149F79419AE5835C8CFCBF6034 | Rating Details |
2022-10-09 11:10:09 -0500 | 1B16E817D4B4C49CC9BE11FE50696836 | Rating Details |
2022-10-10 07:28:37 -0500 | 206CAE2D97906D09A4F53C568DA4B33F | Rating Details |
2022-10-10 22:34:58 -0500 | 20FB19278F30C7654AAD26F68832A39F | Rating Details |
2022-10-08 21:26:07 -0500 | 22AE3115F75FCFB63BDA723149803A7CC3CFFE2FF870153DFA72FF8965A205FF | Rating Details |
2022-10-08 17:25:24 -0500 | 22F926BD91F037C94FAFFB1897038206287A511A4B4C8F9AE7E1A4D62057723C | Rating Details |
2022-10-08 19:49:45 -0500 | 238938F8A35959DAFA9518817DEB65AA | Rating Details |
2022-10-10 14:22:48 -0500 | 2A66CD256FB4F19705DD00B8A11E33F1 | Rating Details |
2022-10-08 17:57:16 -0500 | 33414EF00FC413A7C2F0108D3140DDDA | Rating Details |
2022-10-09 13:25:25 -0500 | 358F6648EA406E9189FA6B57DB48881F | Rating Details |
2022-10-08 13:19:41 -0500 | 3922021E2B4C1A4B610B8FAFE0447925B4441B7A397CBAE1E446B9DE65C2A8E3 | Rating Details |
2022-10-08 19:13:24 -0500 | 3B0C78345431992D7AB429EF0FB699FD | Rating Details |
2022-10-08 19:04:17 -0500 | 43C0C6E62BBB03EF795C48F090C5C67A52516FE15C8B571592C9BE8300DFD93E | Rating Details |
2022-10-11 01:21:25 -0500 | 47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | Rating Details |
2022-10-10 17:00:05 -0500 | 491F86E495D57AD373CE546FA4D9E4C79AB3B56F4BD9907D2CD96BB4578540B1 | Rating Details |
2022-10-08 13:04:20 -0500 | 4DEEBBFB3533AF40E481538B659E0780 | Rating Details |
2022-10-10 22:34:58 -0500 | 4EA0664F8F55B15EB19DDE5E8D132B49C14D06BC274C77D45788F7D5E419029A | Rating Details |
2022-10-14 15:00:20 -0500 | 5183CB1BA1AC3443A35622DA13DF4A9D | Rating Details |
2022-10-10 19:41:12 -0500 | 51CF24E741A18508E181F80408E6E7E109FDDE98B31A9F11F05480731FF485A6 | Rating Details |
2022-10-09 22:56:29 -0500 | 53095A20A1B70303C69D5AB69013813E88BB41710B906CB8D415AB38B40971E6 | Rating Details |
2022-10-08 13:30:29 -0500 | 563DC8324F71A3A79634EE9167BE4BCC | Rating Details |
2022-10-08 18:19:23 -0500 | 566C297B1404D64DF0706C0FAAB850944C04DB435DE4C2B91755E8BAA35F0813 | Rating Details |
2022-10-08 21:26:07 -0500 | 589100D0FF46B1E4801D84B0876F774D | Rating Details |
2022-10-10 12:41:27 -0500 | 5AA696CFD9F8E4BAB84BEC17C3254062D33185EE7FCCCF94D08B4B19D1C6871F | Rating Details |
2022-10-10 19:41:12 -0500 | 5AD0B5581E4AC4683F4A8D75DEB62680 | Rating Details |
2022-10-09 14:03:27 -0500 | 5C46F05F831E79244F60645F43144FBFC3B470DAC34966F9851063B1332734A8 | Rating Details |
2022-10-08 23:01:46 -0500 | 6C4D39819380C974F26A34B6C85405BD | Rating Details |
2022-10-08 17:09:52 -0500 | 7049F1388ECB7675B4DA86EE4998790D97FA3A9D686E9EFE5067E446A8A9A596 | Rating Details |
2022-10-08 17:10:56 -0500 | 71A49EE665957BB16D06E6E5008DA7ECF77E9835F05402A54A630965DD88545E | Rating Details |
2022-10-09 16:56:25 -0500 | 74E1E52EE8EB5E15EA1F55CF08E962E04EEFFEFB76C3E3817BF85EC664EB959B | Rating Details |
2022-10-10 07:28:37 -0500 | 77A10ACCA11F8060822C94413FEA94AEEB34734ADEA095362DDE5E7EC5DAFD1B | Rating Details |
2022-10-08 23:46:22 -0500 | 78B9C824C57C685A61F13A37D207FEFB5B8C026B37764E7663FE06EE42FA090E | Rating Details |
2022-10-08 12:58:24 -0500 | 79A4EB5E995260044AC6A13EBA01ADCF | Rating Details |
2022-10-08 13:04:20 -0500 | 7E55A310EFD019E545F45076DCD657AFB0382C2867953A7FBB46354A9F21EF12 | Rating Details |
2022-10-08 14:28:31 -0500 | 8287473C23000581E5B9AA8BA49800DB | Rating Details |
2022-10-09 12:56:24 -0500 | 87F9A3AD36213601F705EC926F742E9B | Rating Details |
2022-10-08 17:25:24 -0500 | 8DD198F0C6A73EB2D2082CB59C110BDC | Rating Details |
2022-10-08 19:13:24 -0500 | 8E3324F7B5E4CFB7C9F7A4986E563E33288001233DED78A61AFACFBF5411921D | Rating Details |
2022-10-09 22:56:29 -0500 | 944AE5ECD0795D0588CE733337519E2F | Rating Details |
2022-10-08 13:19:41 -0500 | 96E8C2705AF950E4C4C7570121F5F054 | Rating Details |
2022-10-08 19:49:45 -0500 | 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E | Rating Details |
2022-10-11 01:21:25 -0500 | 9795BF8962792425EFA8D2F4F92685B4 | Rating Details |
2022-10-08 19:35:07 -0500 | 9D39800433470057FBA3FE934C493506 | Rating Details |
2022-10-08 23:01:46 -0500 | 9FDF9893DFAB4D45202E6558FAE3342DA24DFA5D58A9F7C14A2CF2DD79A3E176 | Rating Details |
2022-10-10 05:07:15 -0500 | A227869B752DF62F7538C29F2D2D225BAE499F3095FF33A985D81DD1C622A0E8 | Rating Details |
2022-10-08 23:46:22 -0500 | AAA712DCF90BF3400651A10E6C1287D4 | Rating Details |
2022-10-09 00:26:36 -0500 | ABB15BE7A1D45727963172B119C43378 | Rating Details |
2022-10-09 16:56:25 -0500 | AEFCDB949A0D44C0F7CFEB190DED5F1B | Rating Details |
2022-10-09 12:56:24 -0500 | B1C5C2AFA728FEA2FB000676C4042D8A4B1414189951660003FAB89BECD98269 | Rating Details |
2022-10-11 11:53:15 -0500 | B41247447CF0EC824B15AEE3CC37FE478E1F6822AFA1C4AF60487E7916916176 | Rating Details |
2022-10-09 11:10:09 -0500 | C6932488574F7CBE3F1855D6C74B408F3BD254D3CD91A05D2E694BBC284B5C56 | Rating Details |
2022-10-08 13:30:29 -0500 | CAA03362051988C27EED5CDB452B40225425DFFD9383E74818DE69DBAD59B39C | Rating Details |
2022-10-11 02:41:33 -0500 | CB91812DE97D25BB7273DDBB7DC0E70007DEB1A55081EB8A711539A19DD96F3C | Rating Details |
2022-10-09 14:03:27 -0500 | CD856CADFA8F635D3E24419651F09931 | Rating Details |
2022-10-10 17:00:05 -0500 | CD9D49DCCCDDE369B34482B66E49E224 | Rating Details |
2022-10-09 00:26:36 -0500 | D17A207C9E8B385E8469415B4436E6F697CC397E8E53A9B519837DE5261E104F | Rating Details |
2022-10-10 14:22:48 -0500 | D27C30C172A1546D9A97EEA1DA7356DAABD033DE28532862BE3F6D72189EBF93 | Rating Details |
2022-10-08 17:09:52 -0500 | D435632F3F76502DE006C14D17317738 | Rating Details |
2022-10-08 17:10:56 -0500 | D4E9594EC751DEEE7D67FE95734D9AD0 | Rating Details |
2022-10-08 15:04:50 -0500 | D8A371E16F8E203B201DBB1E49C38874 | Rating Details |
2022-10-11 02:41:33 -0500 | DA368F27FC1BF7EB2846FF75845D5F08 | Rating Details |
2022-10-08 15:04:50 -0500 | DBF7CC62890EC65F50A77CF1E08B5F4DF9C6DB2E39C5DF04F49441C4AAA57D91 | Rating Details |
2022-10-14 15:00:20 -0500 | DC8F87AAC0CC114EAB9FCAAAB38D6F9360E014AF6892FC1A5EA7947E1E245E07 | Rating Details |
2022-10-08 16:01:40 -0500 | EBF77488FC3795DF534E34240BE293C677761D229B21C50AC64D02AAFA8556C7 | Rating Details |
2022-10-08 14:28:31 -0500 | EEA39E8B4AB1BEFA47B775A2CE4DCDDD073841F27C81F5E281FC7C6F7F045296 | Rating Details |
2022-10-08 18:19:23 -0500 | EFC78655B041AEE21E7B2EBCC2E19863 | Rating Details |
2022-10-08 13:32:25 -0500 | F092EA4CB202B72F79AC43DE5CAF2DC7D60778EB0698DDEA8AB3EED4323C2245 | Rating Details |
2022-10-08 17:57:16 -0500 | F20119970B4A07DDC4578FCFE4F5CFE163CE013F3082A7545C81A5686016420F | Rating Details |
2022-10-09 13:25:25 -0500 | FA9827AA911192B9110C4BF9A3DE0EBFF9EEB711E98AFA72ED371EC115D99324 | Rating Details |
2022-10-08 13:32:25 -0500 | FBD4C539ADDD48521B69767302DD70B1 | Rating Details |
2022-10-08 19:04:17 -0500 | FC62A0268FFD433E9F592B93E452E2FD | Rating Details |
2022-10-08 12:58:24 -0500 | FCE7F035C82EEE4DC4745E5A85B40BCA27FA681B6028E21EF7B68EB36AA75DC3 | Rating Details |
2022-10-08 16:26:32 -0500 | Rating Details | |
2022-10-10 22:34:58 -0500 | Rating Details | |
2022-10-11 11:53:15 -0500 | Rating Details | |
2022-10-09 22:56:29 -0500 | Rating Details | |
2022-10-14 15:00:20 -0500 | Rating Details | |
2022-10-08 14:28:31 -0500 | Rating Details | |
2022-10-11 02:41:33 -0500 | Rating Details | |
2022-10-08 17:09:52 -0500 | Rating Details | |
2022-10-10 12:41:27 -0500 | Rating Details | |
2022-10-08 19:04:17 -0500 | Rating Details | |
2022-10-08 12:58:24 -0500 | Rating Details | |
2022-10-10 14:22:48 -0500 | Rating Details | |
2022-10-08 17:10:56 -0500 | Rating Details | |
2022-10-08 19:49:45 -0500 | Rating Details | |
2022-10-10 05:07:15 -0500 | Rating Details | |
2022-10-08 23:46:22 -0500 | Rating Details | |
2022-10-09 12:56:24 -0500 | Rating Details | |
2022-10-09 00:26:36 -0500 | Rating Details | |
2022-10-08 21:26:07 -0500 | Rating Details | |
2022-10-08 18:19:23 -0500 | Rating Details | |
2022-10-08 19:35:07 -0500 | Rating Details | |
2022-10-10 17:00:05 -0500 | Rating Details | |
2022-10-09 11:10:09 -0500 | Rating Details | |
2022-10-08 13:04:20 -0500 | Rating Details | |
2022-10-08 23:01:46 -0500 | Rating Details | |
2022-10-08 15:04:50 -0500 | Rating Details | |
2022-10-09 14:03:27 -0500 | Rating Details | |
2022-10-09 16:56:25 -0500 | Rating Details | |
2022-10-08 17:25:24 -0500 | Rating Details | |
2022-10-08 13:19:41 -0500 | Rating Details | |
2022-10-10 19:41:12 -0500 | Rating Details | |
2022-10-08 19:13:24 -0500 | Rating Details | |
2022-10-08 13:30:29 -0500 | Rating Details | |
2022-10-09 13:25:25 -0500 | Rating Details | |
2022-10-08 16:26:32 -0500 | Rating Details | |
2022-10-08 17:57:16 -0500 | Rating Details | |
2022-10-11 01:21:25 -0500 | Rating Details |